维普中文期刊产品整合服务
69篇 您的检索式:作者名="Oxnard GR"
    题名 作者 年代 出处 被引量
1Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib显示文摘Oxnard GR Janjigian YY Arcila ME 0,,19:1
2Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay显示文摘Arcila ME Oxnard GR Nafa K 0,,05:1
3Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer:Distinct natural history of patients with tumors harboring the T790M mutation显示文摘Oxnard GR Arcila ME Sima CS 0,,06:1
4ALCHEMIST:Bringing genomic discovery and targeted therapies to early-stage lung cancer显示文摘Gerber DE Oxnard GR Govindan R 2015Clin Pharmacol Ther2015,97,5:1
5Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to Erlotinib or Gefitinib:Implications for clinical trial design显示文摘Chaft JE Oxnard GR Sima CS 0,,19:1
6Delay of chemotherapy through use of post-progression Erlotinib in patients with EGFR-mutant lung cancer显示文摘Oxnard GR Lo P Jackman DM 0,,15:1
7Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib:implications for clinical trial design显示文摘Chaft JE Oxnard GR Sima CS 0,,19:1
8Maintained sensi-tivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lungcancer recurring after adjuvant erlotinib or gefitinib 显示文摘Oxnard GR Janjigian YY Arcila ME 2011ClinCancer Res2011,17,19:1
9New strategies in over- coming acquired resistance to epidermal growth factor receptor tyro- sine kinase inhibitors in lung cancer显示文摘Oxnard GR Arcila ME Chmielecki J 2011Clin CancerRes2011,17,17:1
10Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay显示文摘Arcila ME Oxnard GR Nafa K 2011Clin Cancer Res2011,17,5:1
11New targetable oncogenes in non- small-cell lung cancer显示文摘Oxnard GR Binder A Jinne PA 2013J Clin Oncol2013,31,8:1
12Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: implications for clinical trial design显示文摘Chaft jE Oxnard GR Sima CS 2011Clin Cancer Res2011,17,19:1
13Maintained Sensitivity to EGFR tyrosine Kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib显示文摘Oxnard GR Janjigian YY Arcila ME 2011Clin Cancer Res2011,17,19:1
14'Pulsatile' high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer显示文摘Grommes C Oxnard GR Kris MG 2011Neuro Oncol2011,13,12:1
15“Pulsatile” high-doseweekly erlotinib for CNS metastases from EGFR mutant non-smallcell lung cancer显示文摘Grommes C Oxnard GR Kris MG 2011Neuro Oncol2011,13,12:1
16Rebiopsy of lung cancer patients with acquired resistance to EGFR in- hibitors and enhanced detection of the T790M mutation using a locked nucleic acid based assay 显示文摘Arcila ME Oxnard GR Nafa K 2011Clin Cancer Res2011,17,5:1
17Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay显示文摘ARCILA ME OXNARD GR NAFA K et d 2011Clin Cancer Res2011,17,5:1
18Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA显示文摘Oxnard GR Paweletz CP Kuang Y 2014Clin Cancer Res2014,20,:1
19Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay显示文摘Arcila ME Oxnard GR Nafa K 0,,:1
20New targetable oncogenes in non-small-cell lung cancer显示文摘Oxnard GR Binder A Jitnne PA 2013J Clln Oncol2013,31,8:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费